David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$700M |
| 2 |
Qualcomm
QCOM
|
+$525M |
| 3 |
Marathon Petroleum
MPC
|
+$522M |
| 4 |
Walmart Inc
WMT
|
+$503M |
| 5 |
Ford
F
|
+$474M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$672M |
| 2 |
Merck
MRK
|
+$476M |
| 3 |
Meta Platforms (Facebook)
META
|
+$392M |
| 4 |
McDonald's
MCD
|
+$372M |
| 5 |
Wells Fargo
WFC
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16% |
| 2 | Consumer Discretionary | 9.85% |
| 3 | Communication Services | 7.8% |
| 4 | Healthcare | 7.67% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
T. Rowe Price
TROW
$24B
| $10.6M | 0.01% |
53,306
-49,298
| -48% | -$9.22M |
|
1327
General Motors
GM
$76.3B
| $10.5M | 0.01% |
178,190
-240,658
| -57% | -$14.1M |
|
|
CVIIU
1328
DELISTED
Churchill Capital Corp VII Units
CVIIU
| $10.5M | 0.01% |
1,053,009
+849,370
| +417% | +$8.52M |
|
|
ETRN
1329
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $10.5M | 0.01% |
1,237,902
+221,757
| +22% | +$1.88M |
|
1330
PUT
Halliburton
HAL
$28.9B
| $10.5M | 0.01% |
455,000
-180,000
| -28% | -$4M |
|
1331
CALL
Albemarle
ALB
$16.7B
| $10.5M | 0.01% |
62,100
+18,300
| +42% | +$2.95M |
|
1332
Cirrus Logic
CRUS
$5.6B
| $10.4M | 0.01% |
122,565
+41,825
| +52% | +$3.35M |
|
1333
PUT
Union Pacific
UNP
$184B
| $10.4M | 0.01% |
+47,400
| New | +$10.6M |
|
1334
CALL
Capital One
COF
$133B
| $10.4M | 0.01% |
67,100
-100,200
| -60% | -$15.1M |
|
|
SWTX
1335
DELISTED
SpringWorks Therapeutics
SWTX
| $10.4M | 0.01% |
125,879
-24,362
| -16% | -$1.85M |
|
1336
PUT
Macy's
M
$6.1B
| $10.4M | 0.01% |
546,800
-7,500
| -1% | -$133K |
|
1337
Vir Biotechnology
VIR
$1.68B
| $10.4M | 0.01% |
219,228
+102,936
| +89% | +$4.68M |
|
1338
Toro Company
TTC
$9.47B
| $10.4M | 0.01% |
94,308
-30,076
| -24% | -$3.31M |
|
1339
PUT
CRISPR Therapeutics
CRSP
$5.52B
| $10.4M | 0.01% |
64,000
-61,500
| -49% | -$7.48M |
|
1340
Opko Health
OPK
$1.1B
| $10.4M | 0.01% |
2,556,582
-979,049
| -28% | -$3.84M |
|
1341
Leggett & Platt
LEG
$1.28B
| $10.3M | 0.01% |
199,458
+94,385
| +90% | +$4.91M |
|
1342
American Express
AXP
$228B
| $10.3M | 0.01% |
62,536
-580,157
| -90% | -$90.9M |
|
1343
Arcturus Therapeutics
ARCT
$408M
| $10.3M | 0.01% |
305,090
+225,152
| +282% | +$7.62M |
|
1344
United Airlines
UAL
$36.9B
| $10.3M | 0.01% |
196,827
-166,037
| -46% | -$9.21M |
|
1345
Bilibili
BILI
$6.91B
| $10.3M | 0.01% |
84,462
-948,847
| -92% | -$103M |
|
1346
Sabra Healthcare REIT
SBRA
$5.23B
| $10.3M | 0.01% |
565,303
+27,815
| +5% | +$495K |
|
1347
BridgeBio Pharma
BBIO
$15.8B
| $10.3M | 0.01% |
168,734
+142,975
| +555% | +$8.17M |
|
1348
CALL
Deere & Co
DE
$175B
| $10.3M | 0.01% |
29,100
+19,600
| +206% | +$7.15M |
|
1349
BP
BP
$113B
| $10.3M | 0.01% |
388,464
-89,733
| -19% | -$2.35M |
|
1350
Regenxbio
RGNX
$531M
| $10.2M | 0.01% |
261,770
+5,545
| +2% | +$198K |
|
Similar funds
David Shaw's Q2 2021 Portfolio in Review
As of Q2 2021, David Shaw held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- David Shaw's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
- David Shaw added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
- David Shaw's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
- David Shaw fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
- David Shaw's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
- David Shaw opened 1,193 new positions and closed 489 in Q2 2021.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.